Kaschina E - Search Results

1

The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets.

Steckelings UM, Rompe F, Kaschina E, Unger T. Steckelings UM, et al. Among authors: kaschina e. Fundam Clin Pharmacol. 2009 Dec;23(6):693-703. doi: 10.1111/j.1472-8206.2009.00780.x. Epub 2009 Oct 9. Fundam Clin Pharmacol. 2009. PMID: 19817870 Review.

2

Angiotensin II type 2 receptors: signalling and pathophysiological role.

Blume A, Kaschina E, Unger T. Blume A, et al. Among authors: kaschina e. Curr Opin Nephrol Hypertens. 2001 Mar;10(2):239-46. doi: 10.1097/00041552-200103000-00013. Curr Opin Nephrol Hypertens. 2001. PMID: 11224700 Review.

3

Differential effects of angiotensin AT1 and AT2 receptors on the expression, translation and function of the Na+-H+ exchanger and Na+-HCO3- symporter in the rat heart after myocardial infarction.

Sandmann S, Yu M, Kaschina E, Blume A, Bouzinova E, Aalkjaer C, Unger T. Sandmann S, et al. Among authors: kaschina e. J Am Coll Cardiol. 2001 Jun 15;37(8):2154-65. doi: 10.1016/s0735-1097(01)01287-6. J Am Coll Cardiol. 2001. PMID: 11419902 Free article.

4

Bradykinin B1 and B2 receptors differentially regulate cardiac Na+-H+ exchanger, Na+-Ca2+ exchanger and Na+-HCO3- symporter.

Sandmann S, Kaschina E, Blume A, Kruse ML, Unger T. Sandmann S, et al. Among authors: kaschina e. Eur J Pharmacol. 2003 Jan 1;458(1-2):3-16. doi: 10.1016/s0014-2999(02)02656-0. Eur J Pharmacol. 2003. PMID: 12498901

5

Angiotensin AT1/AT2 receptors: regulation, signalling and function.

Kaschina E, Unger T. Kaschina E, et al. Blood Press. 2003;12(2):70-88. doi: 10.1080/08037050310001057. Blood Press. 2003. PMID: 12797627 Free article. Review.

6

Drug interactions with angiotensin receptor blockers: a comparison with other antihypertensives.

Unger T, Kaschina E. Unger T, et al. Among authors: kaschina e. Drug Saf. 2003;26(10):707-20. doi: 10.2165/00002018-200326100-00004. Drug Saf. 2003. PMID: 12862505 Review.

7

Genetic kininogen deficiency contributes to aortic aneurysm formation but not to atherosclerosis.

Kaschina E, Stoll M, Sommerfeld M, Steckelings UM, Kreutz R, Unger T. Kaschina E, et al. Physiol Genomics. 2004 Sep 16;19(1):41-9. doi: 10.1152/physiolgenomics.00035.2004. Epub 2004 Jul 6. Physiol Genomics. 2004. PMID: 15238617

8

ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain.

Blume A, Undeutsch C, Zhao Y, Kaschina E, Culman J, Unger T. Blume A, et al. Among authors: kaschina e. Am J Physiol Regul Integr Comp Physiol. 2005 Sep;289(3):R845-50. doi: 10.1152/ajpregu.00672.2004. Epub 2005 May 5. Am J Physiol Regul Integr Comp Physiol. 2005. PMID: 15879055 Free article.

9

The AT2 receptor--a matter of love and hate.

Steckelings UM, Kaschina E, Unger T. Steckelings UM, et al. Among authors: kaschina e. Peptides. 2005 Aug;26(8):1401-9. doi: 10.1016/j.peptides.2005.03.010. Epub 2005 Apr 18. Peptides. 2005. PMID: 16042980 Review.

10

Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.

Kaschina E, Schrader F, Sommerfeld M, Kemnitz UR, Grzesiak A, Krikov M, Unger T. Kaschina E, et al. J Hypertens. 2008 Dec;26(12):2361-73. doi: 10.1097/HJH.0b013e328313e547. J Hypertens. 2008. PMID: 19008714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters